See also this year's filing and all EDGAR filings for this company.
PDF Report 0001100397_2021_Ayala_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001100397, Ayala Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 27,851,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 3,261,000 |
| 2 | PropertyPlantAndEquipmentNet | 2,393,000 |
| 3 | remainder_Assets | 5,021,000 |
| 4 | LiabilitiesCurrent | 3,291,000 |
| 5 | LiabilitiesNoncurrent | 5,055,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,353,943 |
| 9 | ResearchAndDevelopmentExpense | 14,424,874 |
| 10 | remainder_Expenses | 501,721 |
| 11 | remainder_Revenues | 21,286,234 |
| 12 | remainder_NetIncome | 652,139 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 38,526,000 |
| 1 | Liabilities | 8,346,000 |
| 2 | Expenses | 26,280,538 |
| 3 | Revenues | 21,286,234 |
| 4 | StockholdersEquity | 30,180,000 |
| 5 | NetIncome | -4,342,165 |
| 6 | ComprehensiveNetIncome | -4,342,165 |
| 7 | BaseVar | 47,545,456 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.62 |
| 9 | EconomicCapitalRatio | 3.44 |
Edgar->Model Mapping
Feature Distribution
Change over Time
